Michelle LaSpaluto
Finanzdirektor/CFO bei CHIMERIX, INC.
Vermögen: 98 900 $ am 30.04.2024
Aktive Positionen von Michelle LaSpaluto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CHIMERIX, INC. | Finanzdirektor/CFO | 01.12.2023 | - |
Investor Relations Kontakt | 01.01.2019 | 01.12.2023 | |
Public Communications Contact | - | 01.12.2023 |
Karriereverlauf von Michelle LaSpaluto
Ehemalige bekannte Positionen von Michelle LaSpaluto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Comptroller/Controller/Auditor | 01.05.2000 | 01.06.2011 |
Ausbildung von Michelle LaSpaluto
East Carolina University | Masters Business Admin |
Michigan State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Director of Finance/CFO | 1 |
Investor Relations Contact | 1 |
Public Communications Contact | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CHIMERIX, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Michelle LaSpaluto
- Erfahrung